Skip to main content
Joshua Schiffer, MD, Infectious Disease, Seattle, WA

JoshuaTisdellSchifferMD

Infectious Disease • Seattle, WA

Instructor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Schiffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schiffer's full profile

Already have an account?

  • Office

    1959 NE Pacific St
    Seattle, WA 98195
    Phone+1 206-288-1000
    Fax+1 206-606-1025

Education & Training

  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 2005 - 2009
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2002

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2005 - 2026
  • AK State Medical License
    AK State Medical License 2023 - 2024
  • MD State Medical License
    MD State Medical License 2006 - 2007

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Fixed Spatial Structure of CD8+ T Cells in Tissue During Chronic HSV-2 Infection  
    Joshua Schiffer, MD, The Journal of Immunology

Press Mentions

  • Do COVID-19 Tests Still Work?
    Do COVID-19 Tests Still Work?February 10th, 2025
  • Should You Still Be Wearing a Mask? As COVID Rates Climb, Health Experts Say the Answer Is Yes
    Should You Still Be Wearing a Mask? As COVID Rates Climb, Health Experts Say the Answer Is YesJuly 28th, 2022
  • Moderna's Spikevax Scores Full FDA Approval While Omicron BA.2 Picture Emerges
    Moderna's Spikevax Scores Full FDA Approval While Omicron BA.2 Picture EmergesJanuary 31st, 2022
  • Join now to see all

Grant Support

  • Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistenceFRED HUTCHINSON CANCER CENTER2024–2029
  • Development of an Oral Pan-Coronavirus Drug CocktailUNIVERSITY OF WASHINGTON2023–2028
  • Development of an Oral Pan-Coronavirus Drug CocktailUNIVERSITY OF WASHINGTON2023–2028
  • Characterizing determinants of primary KSHV infection among children and adolescents in UgandaFRED HUTCHINSON CANCER CENTER2019–2025
  • Mathematical modeling of optimal therapeutic combinations for HIV cureFRED HUTCHINSON CANCER CENTER2019–2025
  • Intense Validation Of A Mathematical Model Of Herpes Simplex Virus-2 PathogenesisNational Institute Of Allergy And Infectious Diseases2010–2012

Dr. Joshua Schiffer, Dr. Joshua Schiffer, MD, Dr. J Schiffer, Dr. Joshua Tisdell Schiffer